Skip to main content

Subcontracting Opportunities

Subcontracting allows small and disadvantaged businesses to substantially impact the federal procurement preference programs. Due to legislative mandates, federal prime contractors award billions of subcontracting dollars annually to small businesses — Small Business Subcontracting Plan requirements set forth in their contracts include requirements to track participation by veteran-owned, service-disabled veteran-owned, HUBZone, disadvantaged, and women-owned businesses.

USASpending.gov provides information on organizations who have a prime contractor relationship with the NCI. The current Frederick National Laboratory for Cancer Research (FNLCR) prime contractor has significant subcontracting opportunities — see FNLCR Acquisitions for further information.

NCI also maintains a list of its active Indefinite Delivery/Indefinite Quantity (ID/IQ) Prime Contractors. NCI encourages businesses to network and establish teaming arrangements to support these contracting vehicles, which are used to place a variety of orders for supplies and services through processes that do not involve public posting after the base ID/IQ contract(s) have been awarded.

Indefinite Delivery/Indefinite Quantity (ID/IQ) Prime Contractors
Contract Name(s) Contract Specialist Title & Brief Description From Article B.1. Base Period of Performance (Start-End Dates)
IITRI Randall Tiqui Preclinical Toxicology Study of Drugs Developed for Cancer and Other Diseases 07/01/2016 - 06/30/2021
Battelle Randall Tiqui Preclinical Toxicology Study of Drugs Developed for Cancer and Other Diseases 07/01/2016 - 06/30/2022
SRI Randall Tiqui Preclinical Toxicology Study of Drugs Developed for Cancer and Other Diseases 07/01/2016 - 06/30/2023
Southern Research Institute Randal Tiqui Preclinical Toxicology Study of Drugs Developed for Cancer and Other Diseases 07/01/2016 - 06/30/2024
UIC Randal Tiqui Preclinical Toxicology Study of Drugs Developed for Cancer and Other Diseases 07/01/2016 - 06/30/2025
Synergy Randall Tiqui NCI Center for Global Health, Logistics, Data Analysis and Technical Support 09/17/2018 - 09/16/2023
The University of North Carolina at Chapel Hill Randall Tiqui NCI's Genomics Characterization Center 08/31/2019 - 08/30/2024
University of California Randall Tiqui NCI's Genomics Characterization Center 08/31/2019 - 08/30/2024
Washington University in St. Louis Randall Tiqui NCI's Genomics Characterization Center 08/31/2019 - 08/30/2024
Alchem Christine Biser Synthesis of Non-GMP Small Molecules 09/18/2017 - 09/17/2022
22nd Century Technologies Inc. Christina Biser SharePoint Maintenance & Support Services (NCCIH & NCI) 10/17/2015 - 10/16/2020
IIT Research Institute Christy Hunter PREVENT Preclinical Drug Development Program (Efficacy Pool) 01/25/2019 - 01/24/2024
SRI International Christy Hunter PREVENT Efficacy studies 01/25/2019 - 01/24/2024
Illinois Univ, TRL Christy Hunter PREVENT Efficacy studies 01/25/2019 - 01/24/2024
University of Texas, MD Anderson Christy Hunter PREVENT Efficacy studies 01/25/2019 - 01/24/2024
The Research Institute of Fox Chase Cancer Center  Christy Hunter PREVENT Efficacy studies 01/25/2019 - 01/24/2024
University of Alabama at Birmingham Christy Hunter PREVENT Efficacy studies 01/25/2019 - 01/24/2024
University of Oklahoma Health Sciences Center Christy Hunter PREVENT Efficacy studies 01/25/2019 - 01/24/2024
IIT Research Institute Kelly Fowler PREVENT Preclinical Drug Development Program (Toxicology Pool) 01/25/2019 - 01/24/2024
Southern Research Institute Kelly Fowler PREVENT Preclinical Drug Development Program (Toxicology Pool) 01/25/2019 - 01/24/2024
Illinois Univ, TRL Kelly Fowler PREVENT Preclinical Drug Development Program (Toxicology Pool) 01/25/2019 - 01/24/2024
Information Management Services (IMS) Lexi Hudak The purpose of this acquisition is to provide computer systems analysis, programming, data management and maintenance, data analysis, statistical reporting, and documentation services for research efforts conducted by the National Cancer Institute (NCI). Tasks associated with this work include statistical programming and analytic consultation; systems analysis, design, programming, testing documentation maintenance support for computer systems; management, data entry, editing, file management, documentation, and program maintenance support for NCI databases; and computer system administration and resources to support analytic processing, client/server applications, web server applications, and file transfer options in a secure, firewall-protected environment. 08/01/2015 - 07/27/2020
Fisher BioServices, Inc, Lexi Hudak This IDIQ supports the NCI's Chemotherapeutic Agents Repository (NCI-CAR). This contract 1) supports compound acquisition activities related to the DTP anticancer pre-clinical drug evaluation program which seeks to identify new small molecule therapeutic agents and 2) distributes chemicals to intramural and extramural investigators for research purposes. Primary tasks are receipt, registration, storage, analysis, arraying and distribution of small molecules and purified natural products. This contract is also responsible for providing an informational interface with NCI and external investigators that are submitting or requesting research compounds; for updating of the chemical database which includes chemical, inventory, receiving and shipping information; systematic file and record keeping of both current and archival information related to Repository activities; and re-acquisition of samples for continued chemical and biological studies. 08/01/2015 - 07/27/2020
SRI International Lexi Hudak The purpose of this acquisition is to continue implementation of bioanalytical methods and to conduct pharmacokinetic evaluations in animals with compounds of interest to the NCI Therapeutics (NeXT) Program.  07/01/2016 - 06/30/2021
Southern Research Lexi Hudak The purpose of this acquisition is to continue implementation of bioanalytical methods and to conduct pharmacokinetic evaluations in animals with compounds of interest to the NCI Therapeutics (NeXT) Program.  07/01/2016 - 06/30/2021
University of Pittsburgh Lexi Hudak To provide administrative, regulatory, logistical, and information technology support for the Cancer Trials Support Unit (CTSU) to gain operational efficiency for both CTSU and NCTN/MCOs, enhance proficiency, and deliver measurable business value. The Contractor shall build and maintain the operational infrastructure of the CTSU as described within the Statement of Work (SOW). 07/01/2016 - 06/30/2021
IITRI Lexi Hudak The purpose of this acquisition is to continue implementation of bioanalytical methods and to conduct pharmacokinetic evaluations in animals with compounds of interest to the NCI Therapeutics (NeXT) Program.  07/01/2016 - 06/30/2021
Mayo Clinic Lexi Hudak The purpose of this acquisition is to continue implementation of bioanalytical methods and to conduct pharmacokinetic evaluations in animals with compounds of interest to the NCI Therapeutics (NeXT) Program.  07/01/2016 - 06/30/2021
Asterand US  Acquisition Corp Mary Muir Tissue source site for CPTAC Program 09/22/2015 - 09/21/2020
BioMatrix Mary Muir Tissue source site for CPTAC Program 09/29/2015 - 09/28/2020
GLOBAL BIOCLINICAL Mary Muir Tissue source site for CPTAC Program 09/29/2015 - 09/28/2020
INTERNATIONAL GENOMICS CONSORTIUM Mary Muir Tissue source site for CPTAC Program 01/15/2016 - 01/14/2021
ANALYTICAL BIOLOGICAL SERVICES Mary Muir Tissue source site for CPTAC Program 01/19/2016 - 01/18/2021
IIMO (POLAND) Mary Muir Tissue source site for CPTAC Program 12/30/2015 - 12/29/2020
CEDARS-SINAI MEDICAL CENTER Mary Muir Tissue source site for CPTAC Program 03/02/2016 - 03/01/2021
BEAUMONT HEALTH Mary Muir Tissue source site for CPTAC Program 02/24/2016 - 02/23/2021
U. OF CALIFORNIA SAN DIEGO  Mary Muir Tissue source site for CPTAC Program 03/23/2016 - 03/22/2021
BOSTON MEDICAL CENTER Mary Muir Tissue source site for CPTAC Program 02/24/2016 - 02/23/2021
BIOPARTNERS Mary Muir Tissue source site for CPTAC Program 02/24/2016 - 02/23/2021
MRIGlobal Junli Collins Analysis of bulk drug samples and their 
pharmaceutical formulations
08/01/2017 - 07/31/2022
RTI International Junli COllins Analysis of bulk drug samples and their 
pharmaceutical formulations
08/01/2017 - 07/31/2022
SRI International Junli Collins Analysis of bulk drug samples and their 
pharmaceutical formulations
08/01/2017 - 07/31/2022
Advanced Bioscience Laboratories Lindsay Nelson PREVENT Preclinical Drug Development Program: CGMP Production of Vaccines and Biologicals for Cancer Prevention 08/14/2019 - 01/24/2024
International AIDS Vaccine Initiative Lindsay Nelson PREVENT Preclinical Drug Development Program: CGMP Production of Vaccines and Biologicals for Cancer Prevention 08/14/2019 - 01/24/2024
Kindred Biosciences Lindsay Nelson PREVENT Preclinical Drug Development Program: CGMP Production of Vaccines and Biologicals for Cancer Prevention 08/14/2019 - 01/24/2024
IriSys, LLC Mary Muir Manufacture of Oral and Topical Dosage Forms/Brief Decription: Discovery and development of new therapeutic agents for treatment of cancer 06/30/2015 - 06/29/2020
Evotec (US), Inc. Lindsay Nelson Chemical Biology Consortium Screening Libraries Center/ Brief Description: Store and maintain the CBCSLC approximately 135,000 small molecule screening collections 09/30/2015 - 09/29/2020
Information Management Services, Inc. Rachel Weiszer Computing Services for the Division of Cancer Prevention, NCI - provides programming and data management services including project management,  data management, computer programming, computing infrastructure services, website development and systems design and development. 05/10/2013 - 05/09/2020
North American Association of Central Cancer Registries (NAACCR) Kate Muir The objective of this contract is provide support to the North American Association of Central Cancer Registries
(NMCCR) in order to make the National Cancer lnstitute's (NCI) cancer surveillance program more responsive to the needs of the division, institute, and nation, and more integrated with other partners within the national cancer surveillance enterprise.This contract focuses on three specific areas: (1) Strengthening the national capacity for collecting, analyzing, and using comparable cancer registry data for cancer surveillance and research. (2) Developing
and improving methods for assessing the quality and comparability of cancer registry data. This includes, but is not limited to timeliness, completeness, and accuracy. (3) Improving the efficiency and quality of registry operationsthrough promoting established standards, disseminating technical information, and facilitating collaboration among Federal, state, provincial and local registry professionals.
07/01/2014 - 06/30/2021
Vignet Michael Apata This contract shall provide technical services to the Applied Research Program (ARP), in the Division of Cancer Control and Population Sciences (DCCPS) within the National Cancer Institute (NCI). ARP has needs for developmental and technical services in a broad range of content areas, including cancer-associated health behaviors, health services, and outcomes from cancer treatment. Within each of these content areas, common needs are for study management, questionnaire development, and database development and management 09/12/2014 - 09/11/2021
CDM Group Michael Apata Technical Services for the NCI Applied Research Program - This contract provides a broad range of developmental and technical services related to cancer-associated health behaviors, health services and outcomes for cancer treatment. The services include study management, questionnaire development, and database development and management. 09/12/2014 - 09/11/2021
Gunnison Michael Apata Technical Services for the NCI Applied Research Program - This contract provides a broad range of developmental and technical services related to cancer-associated health behaviors, health services and outcomes for cancer treatment. The services include study management, questionnaire development, and database development and management. 09/12/2014 - 09/11/2021
Vsolvit Michael Apata Technical Services for the NCI Applied Research Program - This contract provides a broad range of developmental and technical services related to cancer-associated health behaviors, health services and outcomes for cancer treatment. The services include study management, questionnaire development, and database development and management. 09/12/2014 - 09/11/2021
Westat, Inc Linda Park The Contractor shall provide support for centralized follow-up of participants from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening and the National Lung Screening (NLST) Trials. The PLCO was designed to determine if screening for prostate, lung, colorectal and ovarian cancer can reduce mortality from these cancers. The National Lung Screening Trial (NLST) was a randomized controlled trial designed to determine whether screening for lung cancer with low-dose helical computed tomography (CT) reduces mortality from lung cancer in high-risk individuals relative to screening with chest radiography. 03/01/2016 - 02/28/2021
Bizzell Group Linda Park Tobacco Control Research Scientific and Technical Services Support 09/01/2017 - 08/31/2022
Nationwide Children's Hospital Paula Wilkison Biospcimen Core Resource (BCR) 08/25/2017 - 08/24/2022
Connecticut Department of Public Health Angela Moore Surveillance, Epidemiology and End Results (SEER) Program - collects and reports on population based cancer incidence and survival data on all patients in the legally described catchment area. 05/1/2018 - 04/30/2028
Emory University Angela Moore Surveillance, Epidemiology and End Results (SEER) Program - collects and reports on population based cancer incidence and survival data on all patients in the legally described catchment area. 05/1/2018 - 04/30/2028
Fred Hutchinson Cancer Research Center Angela Moore Surveillance, Epidemiology and End Results (SEER) Program - collects and reports on population based cancer incidence and survival data on all patients in the legally described catchment area. 05/1/2018 - 04/30/2028
Health Research, Inc. Angela Moore Surveillance, Epidemiology and End Results (SEER) Program - collects and reports on population based cancer incidence and survival data on all patients in the legally described catchment area. 05/1/2018 - 04/30/2028
Idaho Hospital Association Angela Moore Surveillance, Epidemiology and End Results (SEER) Program - collects and reports on population based cancer incidence and survival data on all patients in the legally described catchment area. 05/1/2018 - 04/30/2028
Louisiana State University Angela Moore Surveillance, Epidemiology and End Results (SEER) Program - collects and reports on population based cancer incidence and survival data on all patients in the legally described catchment area. 05/1/2018 - 04/30/2028
Massachusetts Department of Public Health Angela Moore Surveillance, Epidemiology and End Results (SEER) Program - collects and reports on population based cancer incidence and survival data on all patients in the legally described catchment area. 05/1/2018 - 04/30/2028
Public Health Institute

Kate Muir

Surveillance, Epidemiology and End Results (SEER) Program - collects and reports on population based cancer incidence and survival data on all patients in the legally described catchment area. 05/1/2018 - 04/30/2028
Cancer Prevention Institute of California (CPIC) Kate Muir Surveillance, Epidemiology and End Results (SEER) Program - collects and reports on population based cancer incidence and survival data on all patients in the legally described catchment area. 05/1/2018 - 04/30/2028
UCSF Kate Muir Surveillance, Epidemiology and End Results (SEER) Program - collects and reports on population based cancer incidence and survival data on all patients in the legally described catchment area. 05/1/2018 - 04/30/2028
University of Hawaii Chris Mills Surveillance, Epidemiology and End Results (SEER) Program - collects and reports on population based cancer incidence and survival data on all patients in the legally described catchment area. 05/1/2018 - 04/30/2028
University of Iowa Chris Mills Surveillance, Epidemiology and End Results (SEER) Program - collects and reports on population based cancer incidence and survival data on all patients in the legally described catchment area. 05/1/2018 - 04/30/2028
University of Kentucky (Research Foundation)  Chris Mills Surveillance, Epidemiology and End Results (SEER) Program - collects and reports on population based cancer incidence and survival data on all patients in the legally described catchment area. 05/1/2018 - 04/30/2028
University of New Mexico Chris Mills Surveillance, Epidemiology and End Results (SEER) Program - collects and reports on population based cancer incidence and survival data on all patients in the legally described catchment area. 05/1/2018 - 04/30/2028
University of Utah Chris Mills Surveillance, Epidemiology and End Results (SEER) Program - collects and reports on population based cancer incidence and survival data on all patients in the legally described catchment area. 05/1/2018 - 04/30/2028
Wisconsin Department of Health Services Chris Mills Surveillance, Epidemiology and End Results (SEER) Program - collects and reports on population based cancer incidence and survival data on all patients in the legally described catchment area. 05/1/2018 - 04/30/2028
University of Southern California Kate Muir Surveillance, Epidemiology and End Results (SEER) Program - collects and reports on population based cancer incidence and survival data on all patients in the legally described catchment area. 05/1/2018 - 04/30/2028
Social and Scientific Systems, Inc Kari Peterson This contract is for support of the Radiation Epidemiology Branch for all phases of epidemiologic studies including initiation of pilot and full-scale field studies, coordination of multi-center studies, arranging for cooperation between NCI and its collaborators, support for study data collection, data acquisition and cleaning, and collection of biological specimens in the US and abroad. It is anticipated that the Contractor will need to provide support to 8-30 studies annually. 08/31/2014 - 09/29/2019
American Type Culture Collection  Lisa Bielen The Contractor shall provide Molecular Epidemiology Assay Support (MEAS) to the Division of Cancer Epidemiology and Genectics. 05/06/2017 - 03/05/2022
Henry Ford Health System Gary Debes The Contractor shall recruit and retain participants, collect and process biospecimens, administer online questionnaires, and link to electronic medical records in support DCEG's NextGeneration Cohort  06/04/2018 - 06/03/2028
Kaiser Foundation Hospitals Gary Debes The Contractor shall recruit and retain participants, collect and process biospecimens, administer online questionnaires, and link to electronic medical records in support DCEG's NextGeneration Cohort  06/04/2018 - 06/03/2028
Sanford Research Gary Debes The Contractor shall recruit and retain participants, collect and process biospecimens, administer online questionnaires, and link to electronic medical records in support DCEG's NextGeneration Cohort  06/04/2018 - 06/03/2028
The University of Chicago Gary Debes The Contractor shall recruit and retain participants, collect and process biospecimens, administer online questionnaires, and link to electronic medical records in support DCEG's NextGeneration Cohort  06/04/2018 - 06/03/2028
Metabolon, Inc. Lisa Bielen The Contractor shall provide metabolomic profiling services for DCEG studies using liquid chromatography and gas chromatography mass spectrometry (LC-MS). 06/14/2017 - 06/13/2022
Fundacion INCIENSA Kathy Sears Evaluation of Single Dose Protection Afforded by the Prophylactic HPV vaccines 08/01/2017 - 07/31/2023
Medidata Solutions Margo Katzper Rave Hosting, Maintenance,  and Professional Services, and License, Hosting, Maintenance, and Professional Services for Rave integrated anicillary services. 09/01/2018 - 08/31/2023
Leidos Biomedical Research Scott Keasey The Contractor shall, in accordance with the provisions of this contract, support the missions and programs assigned under contract with the National Cancer Institute and manage and operate the National Cancer Institute’s Federally Funded Research and Development Center (FFRDC)/Frederick National Laboratory for Cancer Research (FNLCR). The purpose of the FFRDC is to provide a unique biomedical research and development resource for the development of new technologies and the translation of basic science discoveries into novel agents for the prevention, diagnosis, and treatment of cancer, Human Immunodeficiency Virus (HIV)/Acquired Immune Deficiency Syndrome (AIDS), and other diseases in support of the NCI, NIAID, other NIH ICs and other government agencies. The FFRDC serves as a flexible, quick-response mechanism to accomplish the most urgent national/global health initiatives for the NCI/NIH and other government agencies. 06/26/2019 - 06/25/2024 (if all options are exercised)
Stanford Hospital and Clinics Miguel Diaz Laboratory Testing Services for Red Cell Adenosine Deaminase and Purine/Pyrimidine Metabolism Enzymes for Patients with Diamond- Blackfan Anemia   04/09/2015 - 04/08/2020
The Hospital for Sick Children Miguel Diaz Laboratory Testing Services for Red Cell Adenosine Deaminase and Purine/Pyrimidine Metabolism Enzymes for Patients with Diamond- Blackfan Anemia   04/09/2015 - 04/08/2020
Oregon Health & Science University Miguel Diaz Laboratory Testing Services of Chromosome Breakage Analyses for the Inherited Bone Marrow Failure Study 05/20/2015 - 05/19/2020
Datawaves Miguel Diaz Technology Transfer Center TIMS database Maintenance and Upgrades 09/20/2015 (eff. Date 09/24/2015)  -  09/19/2020
Repeat Diagnostics, Inc. Miguel Diaz Laboratory Testing Services of Telomere Length Assays for the Inherited Bone Marrow Failure Study 09/20/2015 (eff. Date 09/24/2015)  -  09/19/2020
Bayer Healthcare LLC Kathy Elliott BPX30 Disposable Endorectal Coils for 3.OT MRI Scanner 09/10/2017-09/17/2022
Bayer Healthcare Reyes Rodriguez Procurement of Coil, Disposable Endorectal 3.0T 07/15/2015 - 07/14/2020
Universite Laval Reyes Rodriguez Services to determine serum concentrations of samples collected by the Hormonal and Reproductive Epidemiology Branch (HREB). 09/01/2015 - 08/31/2020
Artificial Intelligence in Medicine Reyes Rodriguez Surveillance Epidemiology and End Results (SEER) Electronic Data Capture Software Support and Installations 09/26/2015 - 09/25/2020
Gene Dx Adam Hernandez Certified Clinical Genetic Testing for TP53 8/10/2015 - 8/9/2020
Genepria Consulting Inc. Adam Hernandez Statistical and Programming Appplications 09/12/2017-09/11/2022
Leland Standord Junior Univerisity Miguel Diaz Laboratory Services for HDV Antibody (anti0HDV), RNA and genotype testing 04/03/2017 - 04/02/2020
Olink Proteonimes Adam Hernandez Testing Samples Using Inflammation and Cardiometabolic Panels  05/01/2018-04/30/2020
Ganges, Mary Bruce Biological Research Consultant Jolomi Omatete Tissue Culture technician support p to 9000 hours with a minimum of 1400 hours 08/20/2016 - 08/19/2021
Vanderbilt University Medical Center Miguel Diaz Laboratory Testing Services for Circulating Inflammation Markers and Prospective Risk of Gastric Cancer Related to the H Pylor  09/14/2016 - 09/13/2021
Invitae Corporation David Romley Lab Testing/Dicer I Genetic Testing 09/19/2016 - 09/21/2021
D's Ventures LLC Megan Kisamore Procurement of Gardasil-9 Vaccines in support of NCI/CCR 09/18/18 - 09/18/2021
Carl Zeiss Miguel Diaz Maintenance Service Support for Zeiss Confocal and Epifluorescence Microscopes at the NCI CCR Microscopy Core Facilities. 08/01/2019 - 07/31/2024
Roche Diagnostics Corporation Jolomi Omatete BenchMark Ultra Reagents and Consumables 09/22/2019 - 09/21/2024
  Adam Hernandez Erlotinib Tablets 01/24/2020 - 01/23/2023

 

  • Updated: